Synthesis and Evaluation of Tripeptides Containing Asparagine Analogues as Potential Substrates or Inhibitors of Oligosaccharyltransferase

Journal of Organic Chemistry

Volumn 63, Issue 14, 1998, Pages 4767-4778

  Xu, Tong ^a   Werner, R Marshall ^b   Lee, Kwun Chi ^b   Fettinger, James C ^b   Davis, Jeffery T ^b   Coward, James K ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b Bldg 142   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000098929     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo9802123     Document Type: Article

References (67)

1. Imperiali, B.; Hendrickson, T. L. Bioorg. Med. Chem. 1995, 3, 1565-1578.
2. Silberstein, S.; Gilmore, R. FASEB J. 1996, 10, 849-858.
3. Kornfeld, R.; Kornfeld, S. Annu. Rev. Biochem. 1985, 54, 631-664.
4. Clark, R. S.; Banerjee, S.; Coward, J. K. J. Org. Chem. 1990, 55, 6275-6285.
5. Hart, G. W.; Brew, K.; Grant, G. A.; Bradshaw, R. A.; Lennarz, W. J. J. Biol. Chem. 1979, 254, 9747-9753.
6. Welply, J. K.; Shenbagamurthi, P.; Lennarz, W. J.; Naider, F. J. Biol. Chem. 1983, 258, 11856-11863.
7. Challis, B. C.; Challis, J. A. In The Chemistry of Amides; Zabicky, J. Z., Ed.; John Wiley & Sons: London, 1970; Chapter 13.
8. Imperiali, B.; Shannon, K. L. Biochemistry 1991, 30, 4374-4380.
9. Lee, J.; Coward, J. K. Biochemistry 1993, 32, 6794-6801.
10. Bause, E.; Breuer, W.; Peters, S. Biochem J. 1995, 312, 979-985.
11. Zalkin, H. Adv. Enzymol. Relat. Areas Mol. Biol. 1993, 66, 203-309.
12. Xu, T.; Coward, J. K. Biochemistry 1997, 36, 14683-14689.
13. Marshall, R. D. Annu. Rev. Biochem. 1972, 41, 673-702.
14. Stoker, P. W.; O'Leary, M. H.; Boehlein, S. K.; Schuster, S. M.; Richards, N. G. J. Biochemistry 1996, 35, 3024-3030.
15. Boehlein, S. K.; Schuster, S. M.; Richards, N. G. J. Biochemistry 1996, 35, 3031-3037.
16. Bause, E.; Legler, G. Biochem. J. 1981, 795, 639-644.
17. Imperiali, B.; Shannon, K. L.; Unno, M.; Rickert, K. W. J. Am. Chem. Soc. 1992, 114, 7944-7945.
18. Imperiali, B.; Spencer, J. R.; Struthers, M. D. J. Am. Chem. Soc. 1994, 116, 8424-8426.
19. Rathod, P. K.; Tashjian, A. H., Jr.; Abeles, R. H. J. Biol. Chem. 1986, 261, 6461-6469.
20. Hendrickson, T. L.; Spencer, J. R.; Kato, M.; Imperiali, B. J. Am. Chem. Soc. 1996, 118, 7636-7637.
21. Shaw, E. Methods Enzymol. 1994, 244, 649-656.
22. Liu, Y. L.; Schretzman, L.; Coward, J. K. Unpublished results.
23. Pathak, R.; Hendrickson, T. L.; Imperiali, B. Biochemistry 1995, 34, 4179-4185.
24. Smith, R. A.; Copp, L. J.; Donnelly, S. L.; Spencer, R. W.; Krantz, A. Biochemistry 1988, 27, 6568-6573.
25. 26,27 However, few synthetic details and minimal spectral data were provided.
26. Zacharius, R. M. Arch. Biochem. Biophys. 1959, 80, 199-209.
27. Huffman, G. W.; Gesellchen, P. D.; Turner, J. R.; Rothenberger, R. B.; Osborne, H. E.; Miller, F. D.; Chapman, J. L.; Queener, S. W. J. Med. Chem. 1992, 35, 1897-1914.
28. Peterson, R. G.; Richards, F. F.; Handschumacher, R. E. J. Biol. Chem. 1977, 252, 2072-2076.
29. Kaartinen, V.; Williams, J. C.; Tomich, J.; Yates, J. R.; Hood, L. E.; Mononen, I. J. Biol. Chem. 1991, 266, 5860-5869.
30. Lee, J.; Coward, J. K. J. Org. Chem. 1992, 57, 4126-4135.
31. Cornish, V. W.; Hahn, K. M.; Schultz, P. G. J. Am. Chem. Soc. 1996, 118, 8150-8151.
32. Werner, R. M.; Shokek, O.; Davis, J. T. J. Org. Chem. 1997, 62, 8243-8246.
33. A related tripeptide with a β-aspartyl semialdehyde in position 1 predominates as the cyclic aminal; see: Hendrickson, T. L.; Imperiali, B. Biochemistry 1995, 34, 9444-9450.
34. Hwang, D.-R.; Helquist, P.; Shekhani, M. S. J: Org. Chem. 1985, 50, 1264-1271.
35. Carrasco, M.; Jones, R. J.; Kamel, S.; Rapoport, H.; Truong, T. Org. Synth. 1990, 70, 29-34.
36. Baker, E. N.; Hubbard, R. E. Prog. Biophys. Mol. Biol. 1984, 44, 97-180.
37. Marraud, M.; Abbadi, A. Biopolymers 1996, 40, 45-83.
38. Abbadi, A.; Mcharfi, M.; Aubry, A.; Premilat, S.; Boussard, G.; Marraud, M. J. Am. Chem. Soc. 1991, 213, 2729-2735.
39. Lee, K. C.; Falcone, M. L.; Davis, J. T. J. Org. Chem. 1996, 61, 4198-4199.
40. Gavel, Y.; von Heijne, G. Prot. Eng. 1990, 3, 433-442.
41. Pichon-Pesme, V.; Aubry, A.; Abbadi, A.; Boussard, G.; Marraud, M. Int. J. Pept. Protein Res. 1988, 32, 175-182.
42. Montelione, G. T.; Arnold, E.; Meinwald, C.; Stimson, E. R.; Denton, J. B.; Huang, S. G.; Clardy, J.; Scheraga, H. A. J. Am. Chem. Soc. 1984, 106, 7946-7958.
43. Aubry, A.; Abbadi, A.; Boussard, G.; Marraud, M. New J. Chem. 1987, 11, 739-744.
44. 6 over this concentration range. Moreover, the observed NOEs, measured at both 5 and 10 mM for 10, were not concentration dependent. These data indicate that the NOEs were due to intramolecular interactions and not due to intermolecular peptide aggregation.
45. Pachler, K. G. R. Spectrochim. Acta 1963, 19, 2085-2092.
46. Pachler, K. G. R. Spectrochim. Acta 1964, 20, 581-587.
47. Llinás, M.; Klein, M. P. J. Am. Chem. Soc. 1975, 16, 4731-4737.
48. Kessler, H. Angew. Chem., Int. Ed. Engl. 1982, 21, 512-523.
49. Dyson, J. J.; Rance, M.; Houghten, R. A.; Lerner, R. A.; Wright, P. E. J. Mol. Biol. 1988, 201, 161-200.
50. Kemp, D. S.; Curran, T. P.; Boyd, J. G.; Allen, T. J. J. Org. Chem. 1991, 56, 6683-6697.
51. γNH, in Table 2 of ref 8 were inadvertently transposed. This neccesarily alters the conclusions regarding the solution conformation of the nonsubstrate peptide 10. The NMR data for the other peptides in ref 8 appear correct, and the overall conclusion that substrate peptides can adopt the Asx-turn in solution remains the same. We thank Professor Imperiali for helpful correspondence.
52. 20 Because of this particular amino acid substitution, this peptide is unlikely to form an Asx-turn structure, yet it still has a strong affinity for binding to OST.
53. Bordwell, F. G. Acc. Chem. Res. 1988, 21, 456-463.
54. Bordwell, F. G.; Zhang, S.; Zhang, X.-M.; Liu, W.-Z. J. Am. Chem. Soc. 1995, 117, 7092-7096.
55. Stewart, R.; Jones, J. R. J. Am. Chem. Soc. 1967, 89, 5069-5071.
56. It was repeatedly observed that the diazoketone-containing peptide 7 showed slight activity as an OST acceptor substrate. The apparent ability of the diazoketone-containing peptide 7 to serve as a weak OST substrate is an intriguing but, as yet, unexplained observation.
57. Gibbs, B. S.; Coward, J. K. Unpublished results.
58. Boc-DONV-OBn was also synthesized and tested as an inactivator of OST. Interestingly, it also shows slight inhibition toward OST-catalyzed glycosylation. At 10 mM, it shows even more inhibition than the diazoketone 7 (data not shown), suggesting that both 7 and Boc-DONV-OBn may be similar to MMTS and act as nonspecific inactivators of OST. Possibly, they all react with a cysteine that is not in the OST active site, and this cysteine has a structural role rather than a catalytic function.
59. Krahn, J. M.; Kim, J. H.; Burns, M. R.; Parry, R. J.; Zalkin, H.; Smith, J. L. Biochemistry 1997, 36, 11061-11068.
60. Bause, E.; Wesemann, M.; Bartoschek, A.; Breuer, W. Biochem J. 1997, 322, 95-102.
61. Xu, T.; Coward, J. K. Unpublished results.
62. Lee, Y. C. Anal. Biochem. 1990, 189, 151-162.
63. Redfield, A. G.; Kunz, S. D. J. Magn. Reson. 1975, 19, 250-254
64. Bax, A.; Davis, D. G. J. Magn. Reson. 1985, 63, 207-213.
65. Baker, B. R.; Santi, D. V.; Coward, J. K.; Shapiro, H. S.; Jordaan, J. B. J. Heterocycl. Chem. 1966, 3, 425-434.
66. Ivanov, A. K.; Lavut, E. E.; Antonov, A. A.; Karel'skii, V. N. Chem. Nat. Compd. (Engl. Transl.) 1989, 25, 582-589.
67. Sharma, C. B.; Lehle, L.; Tanner, W. Eur. J. Biochem. 1981, 116, 101-108.